Business Immobazyme Raises R50 Million to Scale Biologics PlatformDecember 1, 2025By Greg Stewart03 Mins Read Cape Town, South Africa — December 1st, 2025 — Immobazyme, the stand-out Bio-tech company in South Africa who have been building scalable, cost-effective biologics, has secured an additional R25 million in… Read More
